Sitemap

Pages

• 2017
• 2018
• 2019
• About Us
  • Company Background
    • Vision and Mission
    • Core Values
  • Board of Directors
    • Tan Sri Datin Paduka Siti Sa’diah Binti Sh Bakir
    • Leonard Ariff Bin Abdul Shatar
    • Dato’ Dr. Zaki Morad Bin Mohamad Zaher
    • Dato’ Mohamad Kamarudin Bin Hassan
    • Razalee Bin Amin
    • Zaiton Binti Jamaluddin
    • Dato’ Eisah Binti A. Rahman
    • Datuk Nik Moustpha Bin Hj Nik Hassan
    • Datuk Mohd Radzif Bin Mohd Yunus
  • Group Structure
  • Senior Management
    • Chek Wu Kong
    • Krisnakumara-Reddi
    • Ng Su Yee
    • Wan Amir-Jeffery Bin Wan Abdul Majid
    • Ibrahim Hussin Salleh
    • Shamsul Idham Bin A.Iahad
    • Anita Binti Esa
    • Rama Sockalingam Nagappan
  • Board of Directors
  • Shareholders Information
  • Registrar
  • Awards and Recognition
  • Corporate Governance
    • Constitution
    • Directors Code Of Best Practice
    • Principle 1 (Establish Clear Roles & Responsibilities)
    • Board Charter
      • Board Effectiveness Evaluation
      • Board Effectiveness Evaluation Form
    • Code of Conduct
    • Principle 2 (Strengthen Composition)
      • Sample Board and Chairman Evaluation Form
      • Sample Board Committee Assessment Form
      • Sample Board Committee Evaluation Form
      • Sample Board Evaluation Form
      • Board Remuneration Policy
    • Meeting of members
      • Board Policy on Assessment of Independence of Directors
      • Notice of Meeting of Members
    • Principle 5 (Uphold Integrity in Financial Reporting)
      • External Auditor Independence Policy
    • Principle 7 (Ensure Timely & High Quality Disclosure)
      • Securities Trading Policy
    • Principle 8 (Strengthen Relationship between Company & Shareholders)
      • Shareholder & Investor Communication Policy
  • Terms of Reference
    • Terms of Reference of the Audit and Integrity Committee of Duopharma Biotech Berhad
    • Terms of Reference of the Nomination and Remuneration Committee of Duopharma Biotech Berhad
    • Terms of Reference of the Risk Management and Sustainability Committee of Duopharma Biotech Berhad
  • Halal Initiatives
  • Policy and Procedure
    • Policy and Procedures on the Remuneration for Directors and Senior Management
    • Policy On External Auditors
    • Shareholders and Investors Communication Policy
    • Corporate Disclosure Policies & Procedures
    • Corporate Social Responsibility (CSR) Policy
    • Halal Policy
    • Integrity Policies
      • Anti-Bribery & Anti-Corruption Policy
        • Anti-Bribery & Anti-Corruption Policy
        • Polisi Anti-Rasuah dan Anti-Korupsi
      • Anti-Bribery Management System
        • Anti-Bribery Management System Objectives
        • Anti-Bribery Management System Policy
      • Anti-Money Laundering & Counter Financing Terrorism Policy
        • Anti-Money Laundering & Counter Financing Terrorism Policy
        • Polisi Pencegahan Pengubahan Wang Haram dan Pembiayaan Keganasan
      • Business Ethics Policy
      • Declaration of Interest Policy
        • Declaration of Interest Form
          • Borang Pengisytiharan Kepentingan
          • Declaration of Interest Form
        • Declaration of Interest Policy
        • Polisi Pecanggahan Kepentingan
      • Gift & Hospitality Policy
        • Declaration of Gift
          • Borang Pengisytiharan Penerimaan Hadiah dan Hospitaliti
          • Declaration on Provision of Gifts to 3rd Parties
          • Pengisytiharan bagi Peruntukan Hadiah kepada Pihak Ketiga
          • Received Gift and Hospitality Declaration Form
        • Gift & Hospitality Policy
        • Polisi Hadiah dan Hospitaliti
      • Honorarium Guidelines
        • Garis Panduan Penerimaan Honorarium
        • Honorarium Declaration Form
          • Borang Pengisytiharan Bayaran Honorarium
          • Honorarium Declaration Form
        • Honorarium Receipt Guidelines
      • Integrity Pact Policy
      • Investigation Procedure
      • Sponsorship Policy
        • Polisi Tajaan
        • Sponsorship Declaration Form
          • Sponsorship- Approval Request/Reporting Form
          • Tajaan- Borang Kelulusan/Pelaporan
        • Sponsorship Policy
      • Whistle-Blowing Policy
        • Duopharma Biotech Whistle-Blowing Speak-Up Pharma
        • Polisi Pemberian Maklumat
        • Whistleblowing Policy
    • Sustainability Policies
      • Duopharma (M) Sendirian Berhad SHE Policies
      • Duopharma HAPI Sdn. Bhd. SHE Policies
      • Duopharma Innovation Sdn. Bhd. SHE Policies
      • Duopharma Manufacturing (Bangi) Sdn. Bhd. SHE Policies
      • Duopharma Marketing Sdn. Bhd. SHE Policies
      • Note on Animal Testing
      • Sustainability Policy
• Alimentary
• All Other Therapeutic Products
• Alucid
• Anaesthetics
• Annual General Meeting
• Antacid, Antiflatulent, Antiulcerant
• Anti-Asthma & Copd Products
• Anti-Epileptics
• Anti-Inflammatory and Anti-Rheumatic Products
• Anti-Thrombotic Agents
• Antidiarrhoeals, Oral Electrolyte Replacers & Anti-Inflammatories
• Antiemietic & Antinauseants
• Antifungals, Dermatological
• Antihypertensives
• Antimycobacterials
• Beacolux
• Beta-Blocking Agents
• Blog
• Blood & Blood Forming Organs
• Blood Coagulation System
• Calcium Antagonists
• Cardiac Therapy
• Cardiovascular
• Career Centre
  • Career Development
  • Online Application
• Cerebral & Peripheral Vasotherapeutics
• Champs
• Circular to Shareholders
• Circular to Shareholders
• Consumer Healthcare
• Contact Information
  • Online Feedback
• Corporate Disclosure Policy
• Cough and Cold Preparations
• Dermatological
• Dermoplex
• Directors and Senior Management Remuneration Policy
• Diuretic
• Donna
• Drugs Used in Diabetes
• Email Disclaimer
• Emollients, Protectives
• Ethical Classic
• Ethical Specialist
• Eyeglo
• Flavettes
• Functional Gastro-Intestinal Disorder Drugs
• Gallery
• General Anti-Infectives Systemic
• Genito-Urinary
• Home
• Hospital Solution
• Investor Relations
  • Share Price Performance
  • Financial Highlights
  • Quarterly Reports
  • Annual Report
    • Annual Report Requisition Form
  • Investor Relations
  • Shareholders and Investors Communication Policy
  • AGM 2017 Proceedings
  • Bursa Malaysia Announcements
• Lipid-Regulator / Anti-Atheroma
• Meeting of members
• Mineral Supplements
• Muscle Relaxants
• Musculo-Skeletal
• Nasal Preparations
• Naturalle
• Nervous
• Notice of Annual General Meeting
• Ophalmological / Otological Combinations
• Opthalmologicals
• Oral Aid
• Other CNS Drugs
• Other Drugs for Disorders of Musculo-Skeletal Sys
• Others
• Otological
• Personal Data Protection Act
• Press Releases
• Principle 2 (Strengthen Composition)
• Proceeding and Minutes
• Proceeding and Minutes
• Product
  • Classic Pharmaceutical
  • Consumer Healthcare (CHC)
    • Contest
  • Specialty Pharmaceutical
• Proviton
• Psycholeptics
• Renin-Angiotensin System Agent
• Respiratory
• Ridworm
• Sensory Organs
• Sex Hormone
• Sitemap
• Sustainability Report
• Systemic Antibacterials
• Systemic Antihistamines
• Systemic Corticosteroids
• Systemic Hormonal
• Terms & Conditions
• Terms of Reference of the Halal Committee of Duopharma Biotech Berhad
• Throat Preparations
• Topical Antibacterial and Antivirals
• Topical Corticosteroids
• Various
• Vemizol
• Video
• Vitamins
• Business Activities
  • Duopharma Biotech Berhad
  • Duopharma (M) Sendirian Berhad
  • Duopharma Marketing Sdn. Bhd.
  • Duopharma Manufacturing (Bangi) Sdn. Bhd.
  • Duopharma Innovation Sdn. Bhd.
• Corporate Governance Report

Posts by category

• Category: Video
  • Flavettes Effervescent BM
  • Flavettes Effervescent English
  • Insupen PRO Tamil
  • Insupen PRO Mandarin
  • Insupen PRO English
  • Insupen PRO BM
  • Insupen EZ Tamil
  • Insupen EZ Mandarin
  • Insupen EZ English
  • Insupen EZ BM